Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis
Abstract The HER2-directed antibody-drug conjugate trastuzumab deruxtecan is active against lower levels of HER2 expression than prior-generation therapies. The rate of HER2 expression in brain metastases among patients with initially HER2-null breast cancer is undefined, and receptor discordance in...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Portfolio
2023-10-01
|
| coleção: | npj Breast Cancer |
| Acesso em linha: | https://doi.org/10.1038/s41523-023-00592-5 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|